Latest Triplatin tetranitrate Stories
Researchers at MIT recently revealed a new platinum compound that could eliminate cancer cells more effectively than cisplatin, a popular chemotherapy anticancer drug.
SEATTLE, Nov. 30 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
Daqing Li and colleagues, at the University of Pennsylvania School of Medicine, Philadelphia, have identified in vitro and in mice a way to enhance the anticancer effects of the commonly used platinum-based drug cisplatin.
Researchers in the Department of Chemistry at Wake Forest University in collaboration with colleagues at the Wake Forest University Health Sciences Comprehensive Cancer Center have developed a new class of platinum-based anti-tumor drugs that animal studies have shown to be 10 times more effective than current treatments in destroying certain types of lung cancer cells.
Phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than other drugs, U.S. researchers said.
A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in the journal Proceedings of the National Academy of Sciences.
- an ornament or knob in the shape of a flower